Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 16, 2026 | $6.71 | −13.1% | $50.47B | +1.4% | $6.18 |
| Q1 FY26ended Mar 31, 2026 | Apr 28, 2026 | $8.00 | −16.8% | $50.18B | +2.6% | $10.74 |
| Q4 FY25ended Dec 31, 2025 | — | $2.47 | +36.5% | $49.75B | +9.5% | — |
| Q3 FY25ended Sep 30, 2025 | — | $5.32 | +22.0% | $50.71B | +12.4% | — |
| Q2 FY25ended Jun 30, 2025 | — | $7.72 | −21.6% | $49.78B | +13.4% | — |
| Q1 FY25ended Mar 31, 2025 | — | $9.61 | +0.2% | $48.89B | +14.8% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.81 | −50.1% | $45.44B | +6.6% | — |
| Q3 FY24ended Sep 30, 2024 | — | $4.36 | −20.0% | $45.11B | +5.3% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Elevance Health shares, not any token. As of Jul 16, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $9.85 | — | $43.89B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $9.59 | — | $42.58B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $3.63 | — | $42.65B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $5.45 | — | $42.85B | — | — |